United States Biotechnology & Medical Research

Finch Therapeutics Group Inc (FNCH)

Track

Track

Ticker: FNCH Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Finch Therapeutics Group Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.6
SMISEK JEFFERY A Non-Executive Director
Transaction date
Sale
Price
358.10
Quantity 67,522 -27.1%
Value US$4,241,598
1.6
SMISEK JEFFERY A Non-Executive Director
Transaction date
Sale
Price
66.05
Quantity 63,164 -39.9%
Value US$578,814
1.6
Jeffery A Smisek Director Non-Executive Director
Transaction date
Proposed sale
Price
445.53
Quantity 30,414
Value US$4,154,398
1.6
SMISEK JEFFERY A Non-Executive Director
Transaction date
Sale
Price
3.64
Quantity 1,470 -18.1%
Value US$5,351
1.6
Jeffery A. Smisek Director Non-Executive Director
Transaction date
Proposed sale
Price
3.80
Quantity 1,470
Value US$5,586
1.4
Graf Susan E Non-Executive Director
Transaction date
Purchase
Price
0.27
Quantity 5,010 +inf%
Value US$1,353
3.6
Blaustein Marc Chief Operating Officer Officer
Transaction date
Sale
Price
0.38
Quantity 4,619 -14.2%
Value US$1,755
3.6
Blaustein Marc Chief Operating Officer Officer
Transaction date
Sale
Price
1.39
Quantity 3,636 -10.0%
Value US$5,054
3.0
Vittiglio Joseph Chief Business & Legal Officer Officer
Transaction date
Sale
Price
1.39
Quantity 3,636 -10.4%
Value US$5,054
1.3
Haft Nicholas Non-Executive Director
Transaction date
Purchase
Price
10.18
Quantity 63,850 +1.6%
Value US$649,993
1.3
Haft Nicholas Non-Executive Director
Transaction date
Purchase
Price
17.00
Quantity 882,351 +inf%
Value US$14,999,967
0.9
FERRANTE DOMENIC J Non-Executive Director
Transaction date
Purchase
Price
17.00
Quantity 102,941 +19.3%
Value US$1,749,997
0.9
Crestovo Investor LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
17.00
Quantity 735,294 +6.2%
Value US$12,499,998
1.6
SMISEK JEFFERY A Non-Executive Director
Transaction date
Purchase
Price
17.00
Quantity 88,235 +5.5%
Value US$1,499,995
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-03-29 2024-03-28 S Sale
1.6
SMISEK JEFFERY A
Non-Executive Director
67,522 -27.1%
358.10
US$4,241,598 		67,522 -27.1% 358.10 US$4,241,598
2024-03-29 2024-03-28 S Sale
1.6
SMISEK JEFFERY A
Non-Executive Director
63,164 -39.9%
66.05
US$578,814 		63,164 -39.9% 66.05 US$578,814
2024-03-28 2024-03-28 PrS Proposed sale
1.6
Jeffery A Smisek

Director

Non-Executive Director
30,414
445.53
US$4,154,398 		30,414 445.53 US$4,154,398
2023-11-27 2023-11-22 S Sale
1.6
SMISEK JEFFERY A
Non-Executive Director
1,470 -18.1%
3.64
US$5,351 		1,470 -18.1% 3.64 US$5,351
2023-11-22 2023-11-22 PrS Proposed sale
1.6
Jeffery A. Smisek

Director

Non-Executive Director
1,470
3.80
US$5,586 		1,470 3.80 US$5,586
2023-06-09 2023-06-09 B Purchase
1.4
Graf Susan E
Non-Executive Director
5,010 +inf%
0.27
US$1,353 		5,010 +inf% 0.27 US$1,353
2023-02-23 2023-02-21 S Sale
3.6
Blaustein Marc

Chief Operating Officer

Officer
4,619 -14.2%
0.38
US$1,755 		4,619 -14.2% 0.38 US$1,755
2022-10-25 2022-10-21 S Sale
3.6
Blaustein Marc

Chief Operating Officer

Officer
3,636 -10.0%
1.39
US$5,054 		3,636 -10.0% 1.39 US$5,054
2022-10-25 2022-10-21 S Sale
3.0
Vittiglio Joseph

Chief Business & Legal Officer

Officer
3,636 -10.4%
1.39
US$5,054 		3,636 -10.4% 1.39 US$5,054
2021-12-22 2021-12-20 B Purchase
1.3
Haft Nicholas
Non-Executive Director
63,850 +1.6%
10.18
US$649,993 		63,850 +1.6% 10.18 US$649,993
2021-03-25 2021-03-23 B Purchase
1.3
Haft Nicholas
Non-Executive Director
882,351 +inf%
17.00
US$14,999,967 		882,351 +inf% 17.00 US$14,999,967
2021-03-25 2021-03-23 B Purchase
0.9
FERRANTE DOMENIC J
Non-Executive Director
102,941 +19.3%
17.00
US$1,749,997 		102,941 +19.3% 17.00 US$1,749,997
2021-03-25 2021-03-23 B Purchase
0.9
Crestovo Investor LLC
Non-Executive Director Large shareholder
735,294 +6.2%
17.00
US$12,499,998 		735,294 +6.2% 17.00 US$12,499,998
2021-03-25 2021-03-23 B Purchase
1.6
SMISEK JEFFERY A
Non-Executive Director
88,235 +5.5%
17.00
US$1,499,995 		88,235 +5.5% 17.00 US$1,499,995
Explore more

More insider trading research around Finch Therapeutics Group Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America